Save lives and prevent blindness
by using our AI technology
Get your results in less than a minute!
Less than 25% of the high risk population in the US are screened as the interpretation is expensive and impractical
Over 1B people need an annual check. USA: 75M (+84M prediabetics)
80% of diabetic patients develop DR within 15 years
Glaucoma is a leading cause of blindness after the age of 60
The risk of getting AMD is 30% for those over the age of 75
Zack Dvey-Aharon, PhD, CEO, Co-Founder
Serial entrepreneur, advisor, lecturer. Ph.D. in Machine Learning, 8200
Danny Margalit, COO, Co-Founder
Co-Founder Aladdin (NASDAQ IPO) Product & IP Expert
Izik Itzhakov,
VP Biz Dev
Over 20 years in Healthcare IT. CLEW, iMDsoft, 8200
Amit Wohl,
VP Clinical Studies
Seasoned technology expert
MSc, MBA MIT, BSc Technion
Contact Us
To learn more about AEYE Health, our technology, our solution and any other inquiry, please fill the following form or send an email to info@aeyehealth.com.
New York
200 Park Avenue New York, 17th floor, 10166
Call us at: 1 866 262 7343
Tel Aviv
28 HaArba'a street, South Building, 30th floor. 6473925
Yiannis Monovoukas, PhD
Sean Ianchulev, MD, MPH
Stephen Remondi
Helios Global Investments, Falcon Ventures. CEO of TEI Biosciences, Acquired for $312M
Serial Investor, CEO at Eyenovia
Professor of Ophthalmology at UCSF & Mt. Sinai
Serial Investor, CEO at Xsphera
Board of advisors at Tufts, Partner at R-Cubed
Mike Netz
Serial Angel Investor
Former CEO of Teva Israel